Sveriges Riksbank
CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
| Bid procedure, 2025-10-24 | |
| Bonds | SWEDEN I/L BOND: 3113. SE0009548704, 2027-12-01 SWEDEN I/L BOND: 3114, SE0013748258, 2030-06-01 |
| Bid date | 2025-10-24 |
| Bid times | 09.00-10.00 (CET/CEST) on the Bid date |
| Offered volume (corresponding nominal amount) | 3113: 200 million SEK +/-200 million SEK 3114: 200 million SEK +/-200 million SEK |
| Highest permitted bid volume (corresponding nominal amount) | 3113: 200 million SEK per bid 3114: 200 million SEK per bid |
| Lowest permitted bid volume (corresponding nominal amount) | SEK 10 million per bid |
| Expected allocation time | Not later than 10.15 (CET/CEST) on the Bid date |
| Delivery and payment date | 2025-10-28 |
| Settlement amount | To be paid to the Riksbank's account in Euroclear Sweden AB's securities settlement system SWIFT: VPCSSESSXXX Account: 1 4948 6383 CTM BIC: RIKSSESS ALERT acronym: RIKSBANK |
Stockholm, 2025-10-17
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S18.10.2025 12:00:34 CEST | Press release
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Eavor Technologies Inc.17.10.2025 18:00:00 CEST | Press release
Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom